Transparency Market
Research Reports incorporated a definite business overview and investigation
inclines on "Genotyping Analysis Services Market". This report likewise
incorporates more illumination about fundamental review of the business
including definitions, requisitions and worldwide business sector industry
structure.
An
individual’s genetic makeup is determined by DNA sequences comprising varied
combinations of nucleotides namely, adenine, thymine, cytosine, and guanine.
Alterations of the genetic code and consequent undesirable traits or disease
conditions can occur due to variation in these DNA sequences.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/genotyping-analysis-services.html
Genotyping helps
determine differences in the individual’s genetic makeup wherein the
individuals DNA sequence is examined using biological assays and is compared to
another individuals DNA sequence or a reference sequence. Genotyping analysis
plays an important role in research of genes and gene variants associated with
disease. Single nucleotide polymorphisms (SNPs) are the most common form of
variation which occurs on change in single nucleotide in the genome sequence.
SNP genotyping is rapidly growing as a useful tool in many scientific
disciplines including personalized medicine, plant and animal biotechnology.
The various methods
used for genotyping analysis include polymerase chain reaction (PCR), amplified
fragment length polymorphism detection (AFLPD), random amplified polymorphic
detection (RAPD) of genomic DNA, allele specific oligonucleotide (ASO) probes,
DNA sequencing, restriction fragment length polymorphism identification (RFLPI)
of genomic DNA, and hybridization to DNA microarrays or beads. Genotyping can
be applied to humans as well as microorganisms. Genotyping of viruses or
bacteria may help in tracing the origin of outbreak and thus control the spread
of pathogens. Genotyping develops and provides innovative technologies that
enable multiplex and parallel analysis of biological systems at the cell,
protein, and gene level, facilitating the rapid translation of results into
biology for a better world. Genotyping researchers face major challenge in
studying rare variants most effectively. Whole-genome sequencing is preferred
by some for studying rare variants, however often it is too slow and too
expensive while microarrays are more cost-effective and allow for
higher-throughput.
The global genotyping
analysis services market is segmented based on various services provided by the
key players. These companies provide diverse portfolio of genotyping analysis
service offerings such as human whole genome sequencing services, microarray
services, long read sequencing services, certified service provider program and
other services such as core lab program, service partnerships, analysis and
data management solutions as custom array service, whole genome services and
genome-wide genotyping services. Growing demand from pharmacogenomics,
diagnostic research and animal breeding are some of the factors driving the
market growth. Developing as well as developed countries are expected to
witness increasing demand for genotyping services that are within the reach of
a common man, since people want to understand their genetic make-up in terms of
aesthetic awareness in terms of height, weight, obesity or for diseases such as
diabetes, cancer, cardiovascular and others.
Rising interest in
personalized genomic analysis and growing thrust for using rapidly increasing
knowledge regarding individual genetic variations to personalize diagnosis as
well as treatment is also responsible for driving the growth of the market.
However, this direct to consumer model for providing genetic analysis directly
to an individual has been posing a problem due to concerns from FDA regulatory
agencies about providing health care information directly to non-professionals.
Healthcare providers may make it a general practice for routine DNA sequencing
on patients thus making it needless for individuals to initiate it
themselves.
On the other hand,
technological limitation has been a major constrain to the growth of global
genotyping analysis services market which leads to determination of only small
fraction of an individual’s genotype. Moreover, issues involving intellectual
property and ethics will need to be addressed before personalized medicine can
become a true reality.
Some of the key service
providers in global genotyping analysis market include Affymetrix, Illumina,
Harlan Laboratories, Fluidigm, Life Technologies, Sequenome and Roche
Diagnostics.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include
- North
America
- Asia
Pacific
- Europe
- Rest
of the World
This report provides comprehensive
analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
More
Reports on Biotechnology Market: http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html
About Us:-
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Research Report:-
